FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1992008339> ?p ?o ?g. }

• W1992008339 endingPage "1081" @default.
• W1992008339 startingPage "1075" @default.
• W1992008339 abstract "The aim of this study was to clarify predictive factors for response to eradication therapy in cases of Helicobacter pylori (H. pylori)-positive API2-MALT1-negative gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Sixty-six patients who were examined for H. pylori infection and the presence of the API2-MALT1 chimeric transcript and who underwent H. pylori eradication therapy as first-line therapy, were enrolled in this study. Immunohistochemical markers (p53, Ki-67, and BCL10), microsatellite instability, loss of heterozygosity, serum levels of antibodies (anti-H. pylori and anti-CagA), and markers for gastritis (gastrin and pepsinogens) were examined, and the results were compared between patients whose tumors regressed completely after eradication therapy (responders) and patients whose tumors did not regress (non-responders). Of the 66 patients with localized gastric MALT lymphoma, 47 (71.2%) showed complete remission after eradication therapy. None of the H. pylori-negative (n = 9) and/or API2-MALT1-positive (n = 7) patients responded to antibacterial treatment. Of 44 patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma, 38 (86.4%) showed complete remission after eradication therapy. Titers of antibodies against H. pylori and CagA protein were significantly higher in the responders than in the non-responders (P = 0.0235 and 0.0089, respectively). No significant difference between the groups was observed for the other factors. In conclusion, measurement of titers of serum antibodies to H. pylori and CagA protein may be useful for predicting the response to eradication therapy in patients with H. pylori-positive API2-MALT1-negative gastric MALT lymphoma." @default.
• W1992008339 created "2016-06-24" @default.
• W1992008339 creator A5023958825 @default.
• W1992008339 creator A5024171576 @default.
• W1992008339 creator A5030909676 @default.
• W1992008339 creator A5040876838 @default.
• W1992008339 creator A5043200769 @default.
• W1992008339 creator A5048558405 @default.
• W1992008339 creator A5070130847 @default.
• W1992008339 creator A5075486346 @default.
• W1992008339 creator A5084495158 @default.
• W1992008339 creator A5086850753 @default.
• W1992008339 creator A5089378983 @default.
• W1992008339 date "2009-05-20" @default.
• W1992008339 modified "2023-10-15" @default.
• W1992008339 title "Antibodies to<i>Helicobacter pylori</i>and CagA protein are associated with the response to antibacterial therapy in patients with<i>H. pylori</i>-positive<i>API2-</i><i>MALT1</i>-negative gastric MALT lymphoma" @default.
• W1992008339 cites W1520695706 @default.
• W1992008339 cites W1563487810 @default.
• W1992008339 cites W1594560215 @default.
• W1992008339 cites W1968131030 @default.
• W1992008339 cites W1977578348 @default.
• W1992008339 cites W1987519270 @default.
• W1992008339 cites W1988021144 @default.
• W1992008339 cites W1989287278 @default.
• W1992008339 cites W1990558533 @default.
• W1992008339 cites W1997640923 @default.
• W1992008339 cites W2006338784 @default.
• W1992008339 cites W2030262603 @default.
• W1992008339 cites W2037003203 @default.
• W1992008339 cites W2038426029 @default.
• W1992008339 cites W2041170768 @default.
• W1992008339 cites W2043085105 @default.
• W1992008339 cites W2051899789 @default.
• W1992008339 cites W2058488029 @default.
• W1992008339 cites W2062600859 @default.
• W1992008339 cites W2066900742 @default.
• W1992008339 cites W2069631638 @default.
• W1992008339 cites W2071857408 @default.
• W1992008339 cites W2075626786 @default.
• W1992008339 cites W2076094431 @default.
• W1992008339 cites W2088706963 @default.
• W1992008339 cites W2095215868 @default.
• W1992008339 cites W2097639928 @default.
• W1992008339 cites W2107202569 @default.
• W1992008339 cites W2113345684 @default.
• W1992008339 cites W2114206130 @default.
• W1992008339 cites W2121682088 @default.
• W1992008339 cites W2121692460 @default.
• W1992008339 cites W2123486204 @default.
• W1992008339 cites W2127810485 @default.
• W1992008339 cites W2133308247 @default.
• W1992008339 cites W2141498296 @default.
• W1992008339 cites W2150074331 @default.
• W1992008339 cites W2158874809 @default.
• W1992008339 cites W2159097496 @default.
• W1992008339 cites W2160551988 @default.
• W1992008339 cites W2165073073 @default.
• W1992008339 cites W2301170762 @default.
• W1992008339 cites W4294640205 @default.
• W1992008339 cites W4366064382 @default.
• W1992008339 doi "https://doi.org/10.1111/j.1349-7006.2009.01139.x" @default.
• W1992008339 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19385974" @default.
• W1992008339 hasPublicationYear "2009" @default.
• W1992008339 type Work @default.
• W1992008339 sameAs 1992008339 @default.
• W1992008339 citedByCount "21" @default.
• W1992008339 countsByYear W19920083392012 @default.
• W1992008339 countsByYear W19920083392013 @default.
• W1992008339 countsByYear W19920083392015 @default.
• W1992008339 countsByYear W19920083392016 @default.
• W1992008339 countsByYear W19920083392017 @default.
• W1992008339 countsByYear W19920083392019 @default.
• W1992008339 countsByYear W19920083392020 @default.
• W1992008339 countsByYear W19920083392021 @default.
• W1992008339 countsByYear W19920083392023 @default.
• W1992008339 crossrefType "journal-article" @default.
• W1992008339 hasAuthorship W1992008339A5023958825 @default.
• W1992008339 hasAuthorship W1992008339A5024171576 @default.
• W1992008339 hasAuthorship W1992008339A5030909676 @default.
• W1992008339 hasAuthorship W1992008339A5040876838 @default.
• W1992008339 hasAuthorship W1992008339A5043200769 @default.
• W1992008339 hasAuthorship W1992008339A5048558405 @default.
• W1992008339 hasAuthorship W1992008339A5070130847 @default.
• W1992008339 hasAuthorship W1992008339A5075486346 @default.
• W1992008339 hasAuthorship W1992008339A5084495158 @default.
• W1992008339 hasAuthorship W1992008339A5086850753 @default.
• W1992008339 hasAuthorship W1992008339A5089378983 @default.
• W1992008339 hasBestOaLocation W19920083391 @default.
• W1992008339 hasConcept C104317684 @default.
• W1992008339 hasConcept C121608353 @default.
• W1992008339 hasConcept C126322002 @default.
• W1992008339 hasConcept C159654299 @default.
• W1992008339 hasConcept C203014093 @default.
• W1992008339 hasConcept C2776409635 @default.
• W1992008339 hasConcept C2778204961 @default.
• W1992008339 hasConcept C2778677798 @default.
• W1992008339 hasConcept C2779422922 @default.
• W1992008339 hasConcept C2779526237 @default.

• next